<DOC>
	<DOCNO>NCT02180321</DOCNO>
	<brief_summary>Massive bleeding expect perform distraction osteotomy craniosynostosis patient . Since operation perform young age , many effort perform order reduce total amount bleed transfusion surgery . Our study aim correct coagulopathy massive bleeding transfusion distraction osteotomy use continuous infusion antifibrinolytic agent , tranexamic acid . Tranexamic acid infusion determine accord pharmacokinetic model , change coagulopathy define use thromboelastography .</brief_summary>
	<brief_title>Effect Tranexamic Acid Based Pharmacokinetics Pediatric Patients Undergoing Craniosynostosis Surgery : Randomized Controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Craniosynostoses</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>1 . Patients schedule distraction osteostomy diagnosis Craniosynostosis . 2 . Patients age 2 month 6 year , either whose patient consent 3 . ASA class 1 2 1 . Coagulopathy either PT &gt; INR 1.5 PLT &lt; 50,000/dL 2 . Patients take NSAIDs within 2 day , aspirin within 14 day prior surgery 3 . History convulsive seizure , epilepsy , brain surgery 4 . Known drug allergic reaction tranexamic acid</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Tranexamic acid</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>craniosynostosis</keyword>
</DOC>